`
`Case 2:13-cv-00391-ES-JAD Document 437 Filed 03/19/18 Page 1 of 2 PageID: 7997
`
`UNITED STATES DISTRICT COURT
`DISTRICT OF NEW JERSEY
`
`
`
`JAZZ PHARMACEUTICALS, INC. and
`JAZZ PHARMACEUTICALS IRELAND
`
`
`
`
`
`
`
`LIMITED,
`
`v.
`
`Plaintiffs,
`
`Civil Action No. 13-391 (ES)(JAD)
`(Consolidated)
`
`(Filed Electronically)
`
`AMNEAL PHARMACEUTICALS, LLC, et al.,
`
`
`
`
`Defendants.
`
`
`fl
`
`THIS MATTER having been brought before the Court upon the application of
`
`Plaintiffs Jazz Pharmaceuticals, Inc. and Jazz Pharmaceuticals Ireland Ltd. (collectively, “Jazz”)
`
`(DJ. 374, 389, 395) seeking an order compelling certain discovery from Defendants Lupin
`
`Limited, Lupin Pharmaceuticals, Inc. and Lupin Inc. (collectively, “Lupin”); and the Court
`
`having considered the submissions of Jazz and Lupin in support of and in opposition to the
`
`application; and having heard the arguments of counsel on March 2, 2018; and for good cause
`
`shown:
`
`sh
`IT IS on this \_‘7\§ay of March, 2018,
`ORDERED THAT:
`
`Jazz’s request for an Order compelling Lupin to produce certain discovery is GRANTED
`
`IN PART;
`
`And it is FURTHER ORDERED THAT:
`
`Lupin shall promptly produce the following discovery to Jazz:
`
`
`
`Case 2:13-cv-00391-ES-JAD Document 437 Filed 03/19/18 Page 2 of 2 PageID: 7998
`
`Case 2:13-cv-00391-ES-JAD Document 437 Filed 03/19/18 Page 2 of 2 PagelD: 7998
`
`0 Lab Notebook 1426 concerning sodium oxybate, with appropriate redactions for
`
`relevance to the extent that Lab Notebook 1426 concerns products other than sodium
`
`oxybate;
`
`o The missing pages of Lab Notebook 1427 concerning sodium oxybate, with
`
`appropriate redactions for relevance to the extent that the missing pages for Lab
`
`Notebook 1427 concern products other than sodium oxybate;
`
`o All FDA correspondence concerning a generic Risk Evaluation and Mitigation
`
`Strategy for sodium oxybate in Lupin’s possession, custody, and control, with
`
`appropriate redactions for privilege;
`
`o A Rule 30(b)(6) deposition witness(es) prepared to give testimony consistent with the
`
`parties’ discussion and the Court’s ruling during the March 2, 2018 conference; and
`
`0
`
`Samples of any new batches of Lupin’s sodium oxybate Abbreviated New Drug
`
`Application product, to the extent Lupin or any third party working on Lupin’s behalf
`
`manufactures same.
`
`HON. %£SEgH A. DICKSON
`
`United States Magistrate Judge
`
`cc: Hon. Esther Salas, U.S.D.J.
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
Still Working On It
This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.
Give it another minute or two to complete, and then try the refresh button.
A few More Minutes ... Still Working
It can take up to 5 minutes for us to download a document if the court servers are running slowly.
Thank you for your continued patience.
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
